T3	Treatment 121 124	MTX
T5	Effect 133 144	pneumonitis
T6	Subject 14 115	194 RA patients and 38 PsA patients receiving MTX has identified four RA patients and one PsA patient
T7	Population 79 83	four
T8	Population 100 103	one
T12	Treat-Disorder 84 86	RA
T13	Treat-Disorder 104 107	PsA
T14	Drug 121 124	MTX
T4	Adverse_event 125 132	induced
E1	Adverse_event:T4